These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23140169)

  • 21. [Evidence-based therapeutic drug monitoring for efavirenz].
    Solas C; Gagnieu MC;
    Therapie; 2011; 66(3):197-205. PubMed ID: 21819803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in Dakar, Senegal].
    Seydi M; Diop SA; Dieng AB; Tekpa G; Soumaré M; Diouf A; Niang Kh; Lakh A; Ndiaye I; Fall MB; Diop BM; Sow A; Sow PS
    Bull Soc Pathol Exot; 2009 May; 102(2):99-100. PubMed ID: 19583031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efavirenz-induced exfoliative dermatitis.
    Zhang JC; Sun YT
    Scand J Infect Dis; 2013 Jan; 45(1):70-2. PubMed ID: 22715849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.
    Crespo M; Ribera E; Suárez-Lozano I; Domingo P; Pedrol E; López-Aldeguer J; Muñoz A; Viladés C; Sánchez T; Viciana P; Teira R; García-Alcalde ML; Vergara A; Lozano F; Galindo MJ; Cosin J; Roca B; Terrón A; Geijo P; Vidal F; Garrido M;
    J Antimicrob Chemother; 2009 Jan; 63(1):189-96. PubMed ID: 18988678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
    Echeverría P; Negredo E; Carosi G; Gálvez J; Gómez JL; Ocampo A; Portilla J; Prieto A; López JC; Rubio R; Mariño A; Pedrol E; Viladés C; del Arco A; Moreno A; Bravo I; López-Blazquez R; Pérez-Alvarez N; Clotet B
    Antiviral Res; 2010 Feb; 85(2):403-8. PubMed ID: 19941906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efavirenz as a cause of ataxia in children.
    Hauptfleisch MP; Moore DP; Rodda JL
    S Afr Med J; 2015 Nov; 105(11):897-8. PubMed ID: 26632310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of the psychiatric side-effects of efavirenz.
    Kenedi CA; Goforth HW
    AIDS Behav; 2011 Nov; 15(8):1803-18. PubMed ID: 21484283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of two anti-antiretroviral protocols used for treatment of a cohort of HIV 1-positive patients followed at the Institute of Public Health and Hygiene in Dakar, Senegal].
    Sow PG; Dia AT; Diallo PD; Traore ; Gaye AM
    Med Trop (Mars); 2011 Apr; 71(2):202-3. PubMed ID: 21695888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
    Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
    Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
    Gulick RM; Lalama CM; Ribaudo HJ; Shikuma CM; Schackman BR; Schouten J; Squires KE; Koletar SL; Pilcher CD; Reichman RC; Klingman KL; Kuritzkes DR
    AIDS; 2007 Apr; 21(7):813-23. PubMed ID: 17415036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
    Rahman AP; Eaton SA; Nguyen ST; Bain AM; Payne KD; Bedimo R; Busti AJ
    Pharmacotherapy; 2008 Jul; 28(7):913-9. PubMed ID: 18576906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric complications of efavirenz therapy: suggestions for a new research paradigm.
    Sütterlin S; Vögele C; Gauggel S
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):361-9. PubMed ID: 21037119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacological treatments in HIV patients under antiretroviral therapy.
    Gallego L; Barreiro P; López-Ibor JJ
    AIDS Rev; 2012; 14(2):101-11. PubMed ID: 22627606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum.
    Cavalcante GI; Chaves Filho AJ; Linhares MI; de Carvalho Lima CN; Venâncio ET; Rios ER; de Souza FC; Vasconcelos SM; Macêdo D; de França Fonteles MM
    Eur J Pharmacol; 2017 Mar; 799():7-15. PubMed ID: 28188763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.
    Domingo P; Suárez-Lozano I; Torres F; Teira R; Lopez-Aldeguer J; Vidal F; Muñoz A; Viciana P; Lozano F; Vergara A; Roca B; García Alcalde ML; Cosín J; Terrón A; Galindo MJ; Geijo P; Ribera E; Gonzalez J; Sanchez T; Lacalle JR; Garrido M
    J Antimicrob Chemother; 2008 Jun; 61(6):1348-58. PubMed ID: 18356150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
    Torti C; Maggiolo F; Patroni A; Suter F; Ladisa N; Paraninfo G; Pierotti P; Orani AM; Minoli L; Arici C; Sighinolfi L; Tinelli C; Carosi G;
    J Antimicrob Chemother; 2005 Jul; 56(1):190-5. PubMed ID: 15917286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.
    Palombi L; Nielsen-Saines K; Giuliano M; Marazzi MC
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):807-8. PubMed ID: 21142813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.